Literature DB >> 34131593

Quantitative Checklist for Autism in Toddlers (Q-CHAT). A population screening study with follow-up: the case for multiple time-point screening for autism.

Carrie Allison1, Fiona E Matthews2, Liliana Ruta3, Greg Pasco4, Renee Soufer1, Carol Brayne5, Tony Charman4, Simon Baron-Cohen1.   

Abstract

Objective: This is a prospective population screening study for autism in toddlers aged 18-30 months old using the Quantitative Checklist for Autism in Toddlers (Q-CHAT), with follow-up at age 4. Design: Observational study. Setting: Luton, Bedfordshire and Cambridgeshire in the UK. Participants: 13 070 toddlers registered on the Child Health Surveillance Database between March 2008 and April 2009, with follow-up at age 4; 3770 (29%) were screened for autism at 18-30 months using the Q-CHAT and the Childhood Autism Spectrum Test (CAST) at follow-up at age 4. Interventions: A stratified sample across the Q-CHAT score distribution was invited for diagnostic assessment (phase 1). The 4-year follow-up included the CAST and the Checklist for Referral (CFR). All with CAST ≥15, phase 1 diagnostic assessment or with developmental concerns on the CFR were invited for diagnostic assessment (phase 2). Standardised diagnostic assessment at both time-points was conducted to establish the test accuracy of the Q-CHAT. Main outcome measures: Consensus diagnostic outcome at phase 1 and phase 2.
Results: At phase 1, 3770 Q-CHATs were returned (29% response) and 121 undertook diagnostic assessment, of whom 11 met the criteria for autism. All 11 screened positive on the Q-CHAT. The positive predictive value (PPV) at a cut-point of 39 was 17% (95% CI 8% to 31%). At phase 2, 2005 of 3472 CASTs and CFRs were returned (58% response). 159 underwent diagnostic assessment, including 82 assessed in phase 1. All children meeting the criteria for autism identified via the Q-CHAT at phase 1 also met the criteria at phase 2. The PPV was 28% (95% CI 15% to 46%) after phase 1 and phase 2. Conclusions: The Q-CHAT can be used at 18-30 months to identify autism and enable accelerated referral for diagnostic assessment. The low PPV suggests that for every true positive there would, however, be ~4-5 false positives. At follow-up, new cases were identified, illustrating the need for continued surveillance and rescreening at multiple time-points using developmentally sensitive instruments. Not all children who later receive a diagnosis of autism are detectable during the toddler period. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Entities:  

Keywords:  autism; screening

Mesh:

Year:  2021        PMID: 34131593      PMCID: PMC8166626          DOI: 10.1136/bmjpo-2020-000700

Source DB:  PubMed          Journal:  BMJ Paediatr Open        ISSN: 2399-9772


  39 in total

1.  The CAST (Childhood Asperger Syndrome Test): test accuracy.

Authors:  Jo Williams; Fiona Scott; Carol Stott; Carrie Allison; Patrick Bolton; Simon Baron-Cohen; Carol Brayne
Journal:  Autism       Date:  2005-02

2.  Prevalence of autism-spectrum conditions: UK school-based population study.

Authors:  Simon Baron-Cohen; Fiona J Scott; Carrie Allison; Joanna Williams; Patrick Bolton; Fiona E Matthews; Carol Brayne
Journal:  Br J Psychiatry       Date:  2009-06       Impact factor: 9.319

Review 3.  Restricted and repetitive behaviors in autism spectrum disorders: a review of research in the last decade.

Authors:  Susan R Leekam; Margot R Prior; Mirko Uljarevic
Journal:  Psychol Bull       Date:  2011-07       Impact factor: 17.737

4.  Accuracy of Autism Screening in a Large Pediatric Network.

Authors:  Whitney Guthrie; Kate Wallis; Amanda Bennett; Elizabeth Brooks; Jesse Dudley; Marsha Gerdes; Juhi Pandey; Susan E Levy; Robert T Schultz; Judith S Miller
Journal:  Pediatrics       Date:  2019-10       Impact factor: 7.124

5.  Early Intervention for Children With Autism Spectrum Disorder Under 3 Years of Age: Recommendations for Practice and Research.

Authors:  Lonnie Zwaigenbaum; Margaret L Bauman; Roula Choueiri; Connie Kasari; Alice Carter; Doreen Granpeesheh; Zoe Mailloux; Susanne Smith Roley; Sheldon Wagner; Deborah Fein; Karen Pierce; Timothy Buie; Patricia A Davis; Craig Newschaffer; Diana Robins; Amy Wetherby; Wendy L Stone; Nurit Yirmiya; Annette Estes; Robin L Hansen; James C McPartland; Marvin R Natowicz
Journal:  Pediatrics       Date:  2015-10       Impact factor: 7.124

6.  Early Screening of Autism Spectrum Disorder: Recommendations for Practice and Research.

Authors:  Lonnie Zwaigenbaum; Margaret L Bauman; Deborah Fein; Karen Pierce; Timothy Buie; Patricia A Davis; Craig Newschaffer; Diana L Robins; Amy Wetherby; Roula Choueiri; Connie Kasari; Wendy L Stone; Nurit Yirmiya; Annette Estes; Robin L Hansen; James C McPartland; Marvin R Natowicz; Alice Carter; Doreen Granpeesheh; Zoe Mailloux; Susanne Smith Roley; Sheldon Wagner
Journal:  Pediatrics       Date:  2015-10       Impact factor: 7.124

Review 7.  Identification and evaluation of children with autism spectrum disorders.

Authors:  Chris Plauché Johnson; Scott M Myers
Journal:  Pediatrics       Date:  2007-10-29       Impact factor: 7.124

8.  The CAST (Childhood Asperger Syndrome Test): preliminary development of a UK screen for mainstream primary-school-age children.

Authors:  Fiona J Scott; Simon Baron-Cohen; Patrick Bolton; Carol Brayne
Journal:  Autism       Date:  2002-03

9.  The Autism-Spectrum Quotient (AQ)--adolescent version.

Authors:  Simon Baron-Cohen; Rosa A Hoekstra; Rebecca Knickmeyer; Sally Wheelwright
Journal:  J Autism Dev Disord       Date:  2006-04

10.  A Two-Stage Screening Approach with I-TC and Q-CHAT to Identify Toddlers at Risk for Autism Spectrum Disorder within the Italian Public Health System.

Authors:  Raffaella Devescovi; Lorenzo Monasta; Maura Bin; Giulia Bresciani; Alice Mancini; Marco Carrozzi; Costanza Colombi
Journal:  Brain Sci       Date:  2020-03-23
View more
  7 in total

1.  Do Autism-Specific and General Developmental Screens Have Complementary Clinical Value?

Authors:  Raymond Sturner; Paul Bergmann; Barbara Howard; Kerry Bet; Lydia Stewart-Artz; Shana Attar
Journal:  J Autism Dev Disord       Date:  2022-05-17

2.  Autism screening at 18 months of age: a comparison of the Q-CHAT-10 and M-CHAT screeners.

Authors:  Raymond Sturner; Barbara Howard; Paul Bergmann; Shana Attar; Lydia Stewart-Artz; Kerry Bet; Carrie Allison; Simon Baron-Cohen
Journal:  Mol Autism       Date:  2022-01-03       Impact factor: 7.509

3.  Maternal age, autistic-like traits and mentalizing as predictors of child autistic-like traits in a population-based cohort.

Authors:  Novika Purnama Sari; Pauline W Jansen; Laura M E Blanken; Amber N V Ruigrok; Peter Prinzie; Henning Tiemeier; Simon Baron-Cohen; Marinus H van IJzendoorn; Tonya White
Journal:  Mol Autism       Date:  2022-06-15       Impact factor: 6.476

Review 4.  Tools for early screening of autism spectrum disorders in primary health care - a scoping review.

Authors:  Mateusz Sobieski; Aleksandra Sobieska; Małgorzata Sekułowicz; Maria Magdalena Bujnowska-Fedak
Journal:  BMC Prim Care       Date:  2022-03-15

5.  Maternal depressive symptoms, neonatal white matter, and toddler social-emotional development.

Authors:  Alexandra Lautarescu; Alexandra F Bonthrone; Maximilian Pietsch; Dafnis Batalle; Lucilio Cordero-Grande; J-Donald Tournier; Daan Christiaens; Joseph V Hajnal; Andrew Chew; Shona Falconer; Chiara Nosarti; Suresh Victor; Michael C Craig; A David Edwards; Serena J Counsell
Journal:  Transl Psychiatry       Date:  2022-08-09       Impact factor: 7.989

6.  Maternal steroid levels and the autistic traits of the mother and infant.

Authors:  R Holt; S Baron-Cohen; A Tsompanidis; E Aydin; E Padaigaitė; G Richards; C Allison; G Hackett; T Austin
Journal:  Mol Autism       Date:  2021-07-08       Impact factor: 7.509

7.  Symptoms of Autism Spectrum Disorders Measured by the Qualitative Checklist for Autism in Toddlers in a Large Sample of Polish Toddlers.

Authors:  Alicja Niedźwiecka; Ewa Pisula
Journal:  Int J Environ Res Public Health       Date:  2022-03-05       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.